Literature DB >> 6187912

Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma.

H Kawamitsu, M Miwa, Y Tanaka, H Sakamoto, M Terada, A Hoshi, T Sugimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6187912     DOI： 10.1248/bpb1978.5.900

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN： 0386-846X


× No keyword cloud information.
  4 in total

1.  Benzamide potentiation of the cytotoxicity of bifunctional galactitol [correction of galacticol] in resistant P388 leukemia correlates with inhibition of DNA ligase II.

Authors:  E Institoris; B W Fox; I Pályi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer.

Authors:  Serhan Unlu; Joseph W Kim
Journal:  Curr Oncol Rep       Date:  2022-08-06       Impact factor: 5.945

3.  Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.

Authors:  G Chen; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide and nicotinamide.

Authors:  G Chen; Q C Pan
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.